Fund

Farwing Capital

远翼投资

elsewhere's corpus doesn't contain a profile of Farwing Capital (远翼投资) itself — no coverage of its founding, fund size, or team. What the material does show is it in a deal-making capacity: it led a funding round for TCab Tech , participated as an existing investor topping up in YolTech Therapeutics' Series B (led by the AstraZeneca-CICC medical fund, per a Unity Ventures portfolio note from September 2025) and again in its roughly RMB 500 million Series C led by Loyal Valley Capital in May 2026 . A 2019 Gaorong piece on Aqara's Series B2 also mentions Farwing as backed by Far East Horizon's industrial resources, which Aqara tapped for smart elderly-care and smart-campus deployments . Beyond these appearances in portfolio announcements, elsewhere has not covered the fund directly.

AI-generated — may contain errors, please verify.

Farwing CapitalFund
远翼投资
渲染中…
Mentioned in 7 articles

Coverage